Literature DB >> 33556578

Spatial Evolution of Histologic and Endoscopic Healing in the Left and Right Colon in Patients With Ulcerative Colitis.

Sushrut Jangi1, Ariela K Holmer2, Parambir S Dulai2, Brigid Boland2, Mark Valasek2, Vipul Jairath3, Brian G Feagan3, William J Sandborn2, Siddharth Singh4.   

Abstract

BACKGROUND AND AIMS: Despite increasing interest in histologic remission as a treatment target in ulcerative colitis (UC), the accuracy of histologic findings in left colon in detecting pancolonic histologic remission is unknown.
METHODS: In a retrospective cohort study of patients with endoscopically active pancolitis undergoing treat-to-target interventions, we evaluated the diagnostic accuracy of left-sided (distal to splenic flexure) histologic and endoscopic findings on colonoscopy for detecting histologic and endoscopic healing elsewhere in the colon.
RESULTS: Of 86 patients with moderate to severely active pancolitis who underwent 2 consecutive colonoscopies during treat-to-target interventions, 38% and 51% achieved histologic and endoscopic remission, respectively. Substantial agreement (kappa, 0.67; 95% confidence interval (CI), 0.51-0.83) was observed in histologic findings between left and right colon on follow-up colonoscopy. Histologic, and endoscopic, findings in left colon showed excellent accuracy in detecting pancolonic histologic remission (area under the curve (AUC), 0.96 [95% CI, 0.93-1.0]; misclassification rate, 5.9%), histologic normalization (AUC, 1.0, 0%), endoscopic improvement (AUC, 0.95 [0.96-1.0], 3.5%) and endoscopic remission (AUC, 0.98 [0.96-1.00], 5.8%), respectively.
CONCLUSIONS: In patients with active pancolitis undergoing treat-to-target interventions, histologic and endoscopic findings in the left colon on colonoscopy have excellent accuracy for detecting pancolonic histologic remission, histologic normalization, endoscopic improvement, and endoscopic remission. Flexible sigmoidoscopy may suffice for monitoring histologic and endoscopic activity in patients with pancolitis.
Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IBD; Inflammatory Bowel Disease; STRIDE; Treat-to-Target

Mesh:

Year:  2021        PMID: 33556578      PMCID: PMC9550577          DOI: 10.1016/j.cgh.2021.02.007

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   13.576


  11 in total

1.  Development and validation of the Nancy histological index for UC.

Authors:  Aude Marchal-Bressenot; Julia Salleron; Camille Boulagnon-Rombi; Claire Bastien; Virginie Cahn; Guillaume Cadiot; Marie-Danièle Diebold; Silvio Danese; Walter Reinisch; Stefan Schreiber; Simon Travis; Laurent Peyrin-Biroulet
Journal:  Gut       Date:  2015-10-13       Impact factor: 23.059

2.  [Diagnostic criteria of ulcerative colitis].

Authors:  Takashi Hisabe; Toshiyuki Matsui
Journal:  Nihon Rinsho       Date:  2012-02

3.  Complete histologic normalisation is associated with reduced risk of relapse among patients with ulcerative colitis in complete endoscopic remission.

Authors:  Kelly C Cushing; William Tan; David H Alpers; Vikram Deshpande; Ashwin N Ananthakrishnan
Journal:  Aliment Pharmacol Ther       Date:  2019-11-07       Impact factor: 8.171

4.  ECCO Position Paper: Harmonisation of the approach to Ulcerative Colitis Histopathology.

Authors:  Fernando Magro; Glen Doherty; Laurent Peyrin-Biroulet; Magali Svrcek; Paula Borralho; Alissa Walsh; Fatima Carneiro; Francesca Rosini; Gert de Hertogh; Luc Biedermann; Lieven Pouillon; Michael Scharl; Monika Tripathi; Silvio Danese; Vincenzo Villanacci; Roger Feakins
Journal:  J Crohns Colitis       Date:  2020-06-06       Impact factor: 9.071

5.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

6.  Incremental Benefit of Achieving Endoscopic and Histologic Remission in Patients With Ulcerative Colitis: A Systematic Review and Meta-Analysis.

Authors:  Hyuk Yoon; Sushrut Jangi; Parambir S Dulai; Brigid S Boland; Larry J Prokop; Vipul Jairath; Brian G Feagan; William J Sandborn; Siddharth Singh
Journal:  Gastroenterology       Date:  2020-06-22       Impact factor: 22.682

7.  The clinical significance of right-sided colonic inflammation in patients with left-sided chronic ulcerative colitis.

Authors:  Muthoka L Mutinga; Robert D Odze; Helen H Wang; Jason L Hornick; Francis A Farraye
Journal:  Inflamm Bowel Dis       Date:  2004-05       Impact factor: 5.325

8.  Agreement Between Rectosigmoidoscopy and Colonoscopy Analyses of Disease Activity and Healing in Patients With Ulcerative Colitis.

Authors:  Jean-Frédéric Colombel; Ingrid Ordás; Thomas Ullman; Paul Rutgeerts; Akiko Chai; Sharon O'Byrne; Timothy T Lu; Julián Panés
Journal:  Gastroenterology       Date:  2015-10-23       Impact factor: 22.682

9.  Predictors and outcomes of histological remission in ulcerative colitis treated to endoscopic healing.

Authors:  Sushrut Jangi; Hyuk Yoon; Parambir S Dulai; Mark Valasek; Brigid S Boland; Vipul Jairath; Brian G Feagan; William J Sandborn; Siddharth Singh
Journal:  Aliment Pharmacol Ther       Date:  2020-08-09       Impact factor: 8.171

10.  Segmental Histological Normalisation Occurs in Ulcerative Colitis but Does Not Improve Clinical Outcomes.

Authors:  Britt Christensen; Stephen B Hanauer; Peter R Gibson; Jerrold R Turner; John Hart; David T Rubin
Journal:  J Crohns Colitis       Date:  2020-10-05       Impact factor: 10.020

View more
  1 in total

1.  PICaSSO virtual electronic chromendoscopy accurately reflects combined endoscopic and histological assessment for prediction of clinical outcomes in ulcerative colitis.

Authors:  Olga Maria Nardone; Alina Bazarova; Pradeep Bhandari; Rosanna Cannatelli; Marco Daperno; Jose Ferraz; Martin Goetz; Xianyong Gui; Bu Hayee; Gert De Hertogh; Mark Lazarev; Ji Li; Adolfo Parra-Blanco; Luca Pastorelli; Remo Panaccione; Vincenzo Occhipinti; Timo Rath; Samuel C L Smith; Uday N Shivaji; Gian Eugenio Tontini; Michael Vieth; Vincenzo Villanacci; Davide Zardo; Raf Bisschops; Ralf Kiesslich; Subrata Ghosh; Marietta Iacucci
Journal:  United European Gastroenterol J       Date:  2022-02-23       Impact factor: 4.623

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.